Zero Coupon Pharmacy VIII DST – Securities Investigation
Are you concerned about your investment in Zero Coupon Pharmacy VIII DST? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
Delaware Statutory Trusts, or DSTs, are an alternative for 1031 exchange investors seeking replacement properties, allegedly offering the potential for monthly income and diversification without any on-going landlord duties.
Inland Private Capital Corp. is a sponsor of 1031 exchanges structured through Delaware Statutory Trusts (DSTs), according to its website. The company reportedly filed a form D in 2019 to raise capital from investors for the offering, Zero Coupon Pharmacy VIII DST, according to a filing with the SEC. The total offering amount sold to investors was purportedly $11,924,955.
Risk Factors related to a 1031 Exchange
Property Value Loss – All real estate investments have the potential to lose value over time.
Possibility of Foreclosure – All financed real estate investments have potential for foreclosure.
Illiquid Investments – 1031 exchanges are commonly offered through private placement offerings and are illiquid securities. There is no secondary market for these investments.
Reduction or Elimination of Monthly Cash Flow Distributions – Like any investment in real estate, if a property unexpectedly loses tenants or sustains substantial damage, there is potential for suspension of cash flow distributions.
Tax Status Changes – The income stream and depreciation schedule for any investment property may affect the property owner’s income bracket and/or tax status. An unfavorable tax ruling may cancel deferral of capital gains and result in immediate tax liabilities.
Fees/Expenses – Investors’ returns may be affected by the costs associated with the transaction. and may outweigh the tax benefits.
Potential Lawsuits to Recover Financial Losses
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly recommending high-risk investments to investors.
Despite?the risks of investing in DSTs, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.
Fortunately, FINRA does provide for an arbitration forum for investors to resolve disputes if a broker or brokerage firm makes an?unsuitable investment recommendation?or fails to adequately disclose the risks associated with an investment. It is possible that they could be found liable for investment losses in a FINRA arbitration claim.
If you are concerned about your?investment in Zero Coupon Pharmacy VIII DST, please call the securities attorneys at The White Law Group at 888-637-5510 for a free consultation. For more information on 1031 DST investments please see:
The White Law Group is a national securities fraud, securities arbitration, and investor protection law firm with offices in Chicago, Illinois and Seattle, Washington.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://www.whitesecuritieslaw.com.
Tags: FINRA arbitration, FINRA attorney, Inland 1031 DSTs, securities fraud lawyer, Zero Coupon Pharmacy VIII DST, Zero Coupon Pharmacy VIII DST complaints, Zero Coupon Pharmacy VIII DST help, Zero Coupon Pharmacy VIII DST high commissions, Zero Coupon Pharmacy VIII DST investigation, Zero Coupon Pharmacy VIII DST investors, Zero Coupon Pharmacy VIII DST losses, Zero Coupon Pharmacy VIII DST recovery options, Zero Coupon Pharmacy VIII DST update Last modified: January 19, 2022